Stock Price Quote

IND-SWIFT LTD.

NSE : INDSWFTLTDBSE : 524652ISIN CODE : INE788B01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE17.880.01 (+0.06 %)
PREV CLOSE ( ) 17.87
OPEN PRICE ( ) 17.57
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9111
TODAY'S LOW / HIGH ( )17.57 18.07
52 WK LOW / HIGH ( )6.5 24.29
NSE17.800 (0 %)
PREV CLOSE( ) 17.80
OPEN PRICE ( ) 18.15
BID PRICE (QTY) 17.80 (173)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 45121
TODAY'S LOW / HIGH( ) 17.65 18.20
52 WK LOW / HIGH ( )6.6 23.75
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 06-06 1986
Management Info
S R Mehta - Chairman Gopal Munjal - Managing Director
Registered Office

Address 781,Phase 2,Industrial Area,
Chandigarh,
Union Territory-160002

Phone 0172-4680800 / 2638781

Email corporate@indswift.com

Website www.indswift.com

Registrars Details
Alankit Assignments Ltd.
Alankit House , 4 E/2,Jhandewala Extension,,New Delhi
Listing : BSE, NSE, MCX

NEWS

15Feb Ind-Swift informs about press release
Pursuant to Regulation 47 of the SEBI (Listing obligations and Disclosur..
23Dec Ind-Swift leading gainer in 'B' group
Ind-Swift is the biggest gainer in the BSE's 'B' group. The company is c..
16Nov Ind-Swift informs about newspaper publ
Ind-Swift has informed about Newspaper Publication of Un-audited Financi..
22Sep Ind-Swift informs about change in dire
Ind-Swift has informed that the shareholder in their 36th Annual General..
22Sep Ind-Swift informs about reappointment
Ind-Swift has informed that the shareholder in their 36th Annual General..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit-149.66260.36
Gross Profit -149.66 260.36
Operating Profit 71.0799999999999538.87
Net Sales 1025.614109.58

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddy's Lab (BSE)
peergroup  6445.00 (1.27%)
M.Cap ( in Cr)107511.08
Orchid Pharma (BSE)
peergroup  1217.20 (5.76%)
M.Cap ( in Cr)6173.53
Lincoln Pharma (BSE)
peergroup  737.20 (8.43%)
M.Cap ( in Cr)1476.59
Concord Biotech (BSE)
peergroup  1474.60 (2.39%)
M.Cap ( in Cr)15426.71
Mercury Laboratories (BSE)
peergroup  919.70 (3.87%)
M.Cap ( in Cr)110.36

Shareholding Pattern

PROMOTERS 55.58%
NON-INSTITUTION 44.42%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Ind-Swift Ltd.

Ind-Swift Ltd. was incorporated in the year 1986. Its today's share price is 17.88. Its current market capitalisation stands at Rs 96.85 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4184.96 Cr and Total Income of Rs.4228.13 Cr. The company's management includes Ginny Uppal, Bhupinder Singh, Jagvir Singh Ahluwalia, Anoop Michra, Subhash Chander Galhotra, V K Arora, S P Sharma, Rishav Mehta, Himanshu jain, N R Munjal, V R Mehta, Gopal Munjal, S R Mehta.

It is listed on the BSE with a BSE Code of 524652 , NSE with an NSE Symbol of INDSWFTLTD and ISIN of INE788B01028. It's Registered office is at 781,Phase 2,Industrial AreaChandigarh-160002, Union Territory. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Jain & Associates, JK Jain & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.